Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Aventis patents new series of bone resorption inhibitors

Oct. 4, 2001

MTP inhibitors from Advanced Medicine reportedly useful for atherosclerosis

Oct. 3, 2001

Integrin antagonists under early development at Merck KGaA

Oct. 3, 2001

Pamidronate reduces bone loss in men on prostate cancer treatment

Oct. 3, 2001

Study on stability of synthetic red blood cell substitute reported successful

Oct. 3, 2001

Research on zona pellucida contraceptive vaccine suspended due to inconsistent results

Oct. 2, 2001

AC-2993 continues to show positive effects in type 2 diabetes

Oct. 2, 2001

LXRalpha agonist hypocholamide regulates cholesterol metabolism in animal models

Oct. 2, 2001

New Novartis compounds with potential in osteoporosis

Oct. 1, 2001

New PARP inhibitors described in recent patent by BASF

Oct. 1, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
Insilico Medicine synthesizes new Nav1.8 blockers
BioWorld Science
Insilico Medicine Inc. has identified sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers that are potentially useful for the treatment of pain.